Plans to withdraw popular OTCs from self-selection in France represent an “unprecedented step backwards” by national drug regulator ANSM, according to local self-medication industry association Afipa.
Responding to ANSM’s surprise proposal to move ibuprofen, aspirin and paracetamol (also known as acetaminophen) behind the pharmacy counter, the association warned that the regulator was poised to deliver a substantial blow to France’s under-developed OTC industry. The French self-medication market endured a tough year in 2018 with sales declining by 4.6% to €2.11bn ($2.30bn). Turnover from non-reimbursable products fell at the even faster rate of 5.3%
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?